CCR2 and VEXAS syndrome: Monocyte chemotactic factor chemokine (C-C motif) ligand 2 (CCL2), also called MCP-1, was increased only in the blood of VEXAS patients, whereas transcripts of its receptor CCR2 were significantly decreased (Supplementary Fig. 4E, F).